Matinas BioPharma Holdings Inc (NYSE American:MTNB)
| 0.6821 Delayed Data As of May 13 |  +0.0115 / +1.71%Today’s Change | 0.49 Today|||52-Week Range 1.61 | -32.47% Year-to-Date |
Latest MTNB News | Press Releases
| Matinas Biopharma Holdings, Inc. (MTNB) Reports Q1 Loss, Misses Revenue Estimates May 12 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 0.67 |
| Today’s open | 0.66 |
| Day’s range | 0.65 - 0.70 |
| Volume | 810,858 |
| Average volume (3 months) | 720,769 |
| Market cap | $148.8M |
Data as of 3:39pm ET, 05/13/2022
Growth & Valuation
| Earnings growth (last year) | +4.49% |
| Earnings growth (this year) | -18.18% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -78.95% |
| P/E ratio | NM |
| Price/Sales | 6,368.47 |
| Price/Book | 2.83 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FENCFennec Pharmaceutica... | +0.22 | +4.15% |
| CNCEConcert Pharmaceutic... | +0.50 | +14.49% |
| SLGLSol Gel Technologies... | +0.35 | +6.00% |
| SVRASavara Inc | +0.11 | +9.65% |
Data as of 4:00pm ET, 05/13/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $33.3K |
| Annual profit (last year) | -$23.3M |
| Net profit margin | -69,850.94% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bedminster, New Jersey |
Forecasts
